Autism associated SHANK3 missense point mutations impact conformational fluctuations and protein turnover at synapses

  1. Michael Bucher
  2. Stephan Niebling
  3. Yuhao Han
  4. Dmitry Molodenskiy
  5. Fatemeh Hassani Nia
  6. Hans-Jürgen Kreienkamp
  7. Dmitri Svergun
  8. Eunjoon Kim
  9. Alla S Kostyukova
  10. Michael R Kreutz  Is a corresponding author
  11. Marina Mikhaylova  Is a corresponding author
  1. Humboldt-Universität zu Berlin, Institute of Biology, Germany
  2. European Molecular Biology Laboratory, Germany
  3. University Medical Centre Hamburg-Eppendorf, Germany
  4. Korea Advanced Institute of Science and Technology, Republic of Korea
  5. Washington State University, United States
  6. Leibniz-Institute for Neurobiology, Germany

Abstract

Members of the SH3- and ankyrin-rich repeat (SHANK) protein family are considered as master scaffolds of the post-synaptic density of glutamatergic synapses. Several missense mutations within the canonical SHANK3 isoform have been proposed as causative for the development of autism spectrum disorders (ASDs). However, there is a surprising paucity of data linking missense mutation-induced changes in protein structure and dynamics to the occurrence of ASD-related synaptic phenotypes. In this proof-of-principle study, we focus on two ASD-associated point mutations, both located within the same domain of SHANK3 and demonstrate that both mutant proteins indeed show distinct changes in secondary and tertiary structure as well as higher conformational fluctuations. Local and distal structural disturbances result in altered synaptic targeting and changes of protein turnover at synaptic sites in rat primary hippocampal neurons.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

The following data sets were generated

Article and author information

Author details

  1. Michael Bucher

    Optobiology, Humboldt-Universität zu Berlin, Institute of Biology, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Stephan Niebling

    Molecular Biophysics and High-Throughput Crystallization, European Molecular Biology Laboratory, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Yuhao Han

    Optobiology, Humboldt-Universität zu Berlin, Institute of Biology, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Dmitry Molodenskiy

    Biological Small Angle Scattering, European Molecular Biology Laboratory, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5954-4294
  5. Fatemeh Hassani Nia

    Institute for Human Genetics, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Hans-Jürgen Kreienkamp

    Institute for Human Genetics, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8871-9970
  7. Dmitri Svergun

    Biological Small Angle Scattering, European Molecular Biology Laboratory, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Eunjoon Kim

    Center for Synaptic Brain Dysfunctions, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  9. Alla S Kostyukova

    The Gene and Linda Voiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Michael R Kreutz

    RG Neuroplasticity, Leibniz-Institute for Neurobiology, Magdeburg, Germany
    For correspondence
    michael.kreutz@zmnh.uni-hamburg.de
    Competing interests
    The authors declare that no competing interests exist.
  11. Marina Mikhaylova

    Optobiology, Humboldt-Universität zu Berlin, Institute of Biology, Berlin, Germany
    For correspondence
    marina.mikhaylova@hu-berlin.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7646-1346

Funding

Deutsche Forschungsgemeinschaft (MI1923/1-2)

  • Marina Mikhaylova

Deutsche Forschungsgemeinschaft (FOR2419 TP2)

  • Marina Mikhaylova

Deutsche Forschungsgemeinschaft (EXC-2049-390688087)

  • Marina Mikhaylova

Leibniz-Gemeinschaft (Neurotranslation)

  • Michael R Kreutz

Deutscher Akademischer Austauschdienst (Research Stays for University Academics and Scientists Award)

  • Alla S Kostyukova

Hamburg Landesforschungsförderung (LFF-FV76)

  • Marina Mikhaylova

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments were carried out in accordance with the European Communities Council Directive (2010/63/EU) and the Animal Welfare Law of the Federal Republic of Germany (Tierschutzgesetz der Bundesrepublik Deutschland, TierSchG) approved by the local authorities of the city-state Hamburg (Behörde für Gesundheit und Verbraucherschutz, Fachbereich Veterinärwesen) and the animal care committee of the University Medical Center Hamburg-Eppendorf.

Copyright

© 2021, Bucher et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Michael Bucher
  2. Stephan Niebling
  3. Yuhao Han
  4. Dmitry Molodenskiy
  5. Fatemeh Hassani Nia
  6. Hans-Jürgen Kreienkamp
  7. Dmitri Svergun
  8. Eunjoon Kim
  9. Alla S Kostyukova
  10. Michael R Kreutz
  11. Marina Mikhaylova
(2021)
Autism associated SHANK3 missense point mutations impact conformational fluctuations and protein turnover at synapses
eLife 10:e66165.
https://doi.org/10.7554/eLife.66165

Share this article

https://doi.org/10.7554/eLife.66165

Further reading

    1. Neuroscience
    Walter Senn, Dominik Dold ... Mihai A Petrovici
    Research Article

    One of the most fundamental laws of physics is the principle of least action. Motivated by its predictive power, we introduce a neuronal least-action principle for cortical processing of sensory streams to produce appropriate behavioral outputs in real time. The principle postulates that the voltage dynamics of cortical pyramidal neurons prospectively minimizes the local somato-dendritic mismatch error within individual neurons. For output neurons, the principle implies minimizing an instantaneous behavioral error. For deep network neurons, it implies the prospective firing to overcome integration delays and correct for possible output errors right in time. The neuron-specific errors are extracted in the apical dendrites of pyramidal neurons through a cortical microcircuit that tries to explain away the feedback from the periphery, and correct the trajectory on the fly. Any motor output is in a moving equilibrium with the sensory input and the motor feedback during the ongoing sensory-motor transform. Online synaptic plasticity reduces the somatodendritic mismatch error within each cortical neuron and performs gradient descent on the output cost at any moment in time. The neuronal least-action principle offers an axiomatic framework to derive local neuronal and synaptic laws for global real-time computation and learning in the brain.

    1. Neuroscience
    Mengqiao Cui, Xiaoyuan Pan ... Jun-Li Cao
    Research Article

    Memory impairment in chronic pain patients is substantial and common, and few therapeutic strategies are available. Chronic pain-related memory impairment has susceptible and unsusceptible features. Therefore, exploring the underlying mechanisms of its vulnerability is essential for developing effective treatments. Here, combining two spatial memory tests (Y-maze test and Morris water maze), we segregated chronic pain mice into memory impairment-susceptible and -unsusceptible subpopulations in a chronic neuropathic pain model induced by chronic constrictive injury of the sciatic nerve. RNA-Seq analysis and gain/loss-of-function study revealed that S1P/S1PR1 signaling is a determinant for vulnerability to chronic pain-related memory impairment. Knockdown of the S1PR1 in the dentate gyrus (DG) promoted a susceptible phenotype and led to structural plasticity changes of reduced excitatory synapse formation and abnormal spine morphology as observed in susceptible mice, while overexpression of the S1PR1 and pharmacological administration of S1PR1 agonist in the DG promoted an unsusceptible phenotype and prevented the occurrence of memory impairment, and rescued the morphological abnormality. Finally, the Gene Ontology (GO) enrichment analysis and biochemical evidence indicated that downregulation of S1PR1 in susceptible mice may impair DG structural plasticity via interaction with actin cytoskeleton rearrangement-related signaling pathways including Itga2 and its downstream Rac1/Cdc42 signaling and Arp2/3 cascade. These results reveal a novel mechanism and provide a promising preventive and therapeutic molecular target for vulnerability to chronic pain-related memory impairment.